Pb2305: efgartigimod: clinical development of a novel fcrn antagonist in the treatment of autoimmune diseases P. Knoebl,H. de Haard,W. Parys,P. Ulrichts, F. Rocca,A. Guglietta, J. AyguasanosaHemaSphere(2022)引用 0|浏览0暂无评分关键词novel fcrn antagonist,efgartigimodAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要